Differential Noradrenergic Modulation of Monetary Reward and Visual Erotic Stimulus Processing

Area of Science:

• Neuroscience
• Psychopharmacology
• Neuroimaging

Background:

• The noradrenergic system plays a role in reward processing, but its specific effects on neural correlates of primary reinforcers are not fully understood.
• Previous research suggested reboxetine (a noradrenergic antidepressant) may dampen reward system activity, but this was counterintuitive given its interaction with the dopamine system.

Purpose of the Study:

• To investigate the effects of reboxetine and amisulpride on neural reward prediction error signaling using functional magnetic resonance imaging (fMRI).
• To explore the differential modulation of the neural reward system by reboxetine in response to primary (erotic) versus secondary (monetary) reinforcers.

Main Methods:

• A randomized, double-blind, within-subject crossover design involving 17 healthy males.
• Participants received reboxetine, amisulpride, or placebo for 7 days each.
• fMRI was used to assess neural activity in the nucleus accumbens (Nacc) during visual erotic stimulation and a monetary incentive task.

Main Results:

• Reboxetine significantly attenuated Nacc activations during visual erotic stimulation, correlating with diminished sexual functioning.
• Neural activity related to reward prediction error and monetary reward expectation in the Nacc remained unimpaired under reboxetine.
• Amisulpride did not alter neural activations or behavioral processing in either task compared to placebo.

Conclusions:

• Reboxetine differentially modulates the neural reward system, attenuating responses to primary reinforcers like erotic stimuli.
• Noradrenergic agents like reboxetine do not impair reward prediction error signaling or responses to secondary rewards.
• These findings highlight distinct neural pathways involved in processing different types of rewards and the specific impact of noradrenergic modulation.